A detailed history of Trek Financial, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Trek Financial, LLC holds 7,230 shares of ABT stock, worth $949,371. This represents 0.07% of its overall portfolio holdings.

Number of Shares
7,230
Previous 6,146 17.64%
Holding current value
$949,371
Previous $638,000 29.15%
% of portfolio
0.07%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $108,475 - $128,052
1,084 Added 17.64%
7,230 $824,000
Q2 2024

Aug 12, 2024

BUY
$100.73 - $112.44 $126,113 - $140,774
1,252 Added 25.58%
6,146 $638,000
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $535,990 - $591,978
4,894 New
4,894 $556,000
Q2 2023

Aug 11, 2023

BUY
$100.78 - $112.29 $201,358 - $224,355
1,998 New
1,998 $217,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $230B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Trek Financial, LLC Portfolio

Follow Trek Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trek Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trek Financial, LLC with notifications on news.